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Summary
Cerebral deposition of -amyloid (A) peptides is an
invariant pathological hallmark in brains of patients
with Alzheimer’s disease (AD) and transgenic mice co-
expressing familial AD-linked APP and PS1 variants.
We now report that exposure of transgenic mice to an
“enriched environment” results in pronounced reduc-
tions in cerebral A levels and amyloid deposits,
compared to animals raised under “standard hous-
ing” conditions. The enzymatic activity of an A-
degrading endopeptidase, neprilysin, is elevated in
the brains of “enriched” mice and inversely corre-
lated with amyloid burden. Moreover, DNA microarray
analysis revealed selective upregulation in levels of
transcripts encoded by genes associated with learn-
ing and memory, vasculogenesis, neurogenesis, cell
survival pathways, A sequestration, and prostaglan-
din synthesis. These studies provide evidence that
environmental enrichment leads to reductions in
steady-state levels of cerebral A peptides and amy-
loid deposition and selective upregulation in levels of
specific transcripts in brains of transgenic mice.
Introduction
Alzheimer’s disease (AD), the major cause of adult-
onset dementia, is associated with progressive memory*Correspondence: ssisodia@drugs.bsd.uchicago.edu (S.S.S.);
karoly+@pitt.edu (K.M.)loss and severe cognitive decline. These clinical fea-
tures are associated with deposition of β-amyloid (Aβ)
peptides and neuronal loss in the cerebral cortex and
hippocampal formation. Aβ peptides are liberated from
the larger transmembrane amyloid precursor protein
(APP) by the action of BACE 1 and γ-secretase. Early-
onset, familial forms of the disease (FAD) are caused
by expression of mutant variants of APP, presenilin 1
(PS1) or presenilin 2 (PS2) (Price and Sisodia, 1998).
Expression of these mutant genes leads to the overpro-
duction of highly fibrillogenic Aβ42 peptides, and coex-
pression of FAD-linked PS1 and APP leads to ac-
celerated amyloid deposition in the hippocampus and
cerebral cortices of transgenic mice (Price and Si-
sodia, 1998).
In view of compelling evidence that has emerged to
suggest that the brain, and the hippocampus and cor-
tex in particular, exhibit environment-induced plasticity
throughout adult life, and the demonstration that APP
processing and Aβ production can be modulated by
synaptic activity (Kamenetz et al., 2003; Nitsch et al.,
1993), we tested the hypothesis that Aβ amyloidogen-
esis could be modulated by environmental “experi-
ence.” The classical paradigm that has been employed
to assess environment-induced plasticity is termed
“environmental enrichment” and involves placing ani-
mals in large cages that contain running wheels, color-
ful tunnels, and assorted toys. Indeed, it is well estab-
lished that animals placed in such environments exhibit
enhanced memory function (Fordyce and Wehner,
1993), increased survival of newborn cells in the den-
tate gyrus (Kempermann et al., 1997), and enhanced
recovery from lesion-induced memory deficits (Rampon
et al., 2000). Morphologically, exposure to environmen-
tal enrichment is manifested in an increase in numbers
of dendritic spines, extent of branching, and number of
synapses per neuron (for review, see van Praag et al.
[2000]), implying that neural outcomes are a function of
the degree and nature of environmental experience.
We employed a well-established mouse model in
which coexpression of familial AD (FAD)-linked APP
“Swedish” (APPswe) and PS1E9 polypeptide variants
leads to Aβ deposition throughout the hippocampus
and cortex (Lazarov et al., 2002). A cohort of newly
weaned, male APPswe X PS1E9 mice were exposed
to an enriched environment conditions for 5 months,
after which time the brains of these animals were exam-
ined using biochemical and histological approaches.
We now show that environmental enrichment leads to
marked reductions in both the steady-state levels of Aβ
peptides and Aβ deposition in brains of enriched mice
compared to mice in standard housing conditions. In
parallel, we observe a significant elevation in the activ-
ity of an Aβ-degrading protease, neprilysin (NEP) in
brain extracts from enriched mice compared to stan-
dard-housed animals. Using high-density Affymetrix
GeneChips microarray technologies, we show that, in
hippocampi of younger mice, the majority of transcripts
that were significantly upregulated in enriched mice
corresponded to immediate early genes (IEG), but tran-
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702Figure 1. Reduced Amyloid Deposition in the
Hippocampus and Cortex of Enriched versus
Standard Housing Mice
(A) Immunohistochemical analysis of brain
sections of standard housing (SH, [Aa]–[Ad],
hippocampus; [Ai]–[Al], cortex) and enriched
mice (Enr, [Ae]–[Ah], hippocampus; [Am]–
[Ap], cortex) immunolabeled with anti-Aβ
3D6 antibodies. Pictures were taken from
four enriched and four standard housing
mice. Scale bar, 250 m.
(B) Quantitative analysis of volume of amy-
loid burden in brains of standard housing
and enriched mice. Volume is in arbitrary
units (mean cubic pixels ± SE, ANOVA, p %
0.0374).
(C) Reduced number and size of thioflavine
S-stained amyloid deposits in the hippocam-
pus and cortex of enriched versus standard
housing mice. Thioflavine S-positive amyloid
deposits in brain sections of enriched (Enr;
Ca, Cb, Ce, and Cf) and standard housing
mice (SH; Cc, Cd, Cg, Ch). Size and abun-
dance of thioflavine-positive structures in
enriched (a = low power; b = high power) is
reduced compared to standard housing
mice (c = low power; d = high power). For
(Ca) and (Cc), scale bar, 250 m. For (Cb)
and (Cd), scale bar, 120 m. Double labeling
with thioflavine S and anti-Aβ 3D6 antibodies
reveals overlap staining at the core of the
amyloid deposits, while the periphery of the
deposit is stained mostly with anti-Aβ 3D6
antibodies (Cg and Ch). In contrast, the vast
majority of amyloid deposits in brain sec-
tions of enriched mice had little 3D6-positive
peripheral staining (Ce and Cf). Scale bar,
60 m.
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703Figure 2. Amyloid Deposition as a Function of Activity Level
(A) Activity level of mice during exposure to enriched environment. Activity level of the mice was observed and recorded periodically. The
time spent by the mice for each activity group is expressed as a percentage of total observation time.
(B) Amyloid deposition in the brain of enriched mice as a function of their activity level. Amyloid deposition in the brains of enriched mice
was detected and analyzed as described above (see Figures 1A and 1B). Levels of amyloid deposition were found to be inversely correlated
with the activity level of the mice (mean ± SE; ANOVA, p % 0.0116).scripts encoding polypeptides involved in Aβ seques-
tration, endothelial function, and phospholipid metabo-
lism were also elevated. This study provides evidence
that steady-state levels of cerebral Aβ peptides and
amyloid deposition can be modulated by environmen-
tal factors.
Results
Environmental Enrichment Leads
to Reduced A Deposition
At 1 month of age, an experimental group of nine male
APPswe X PS1E9 mice were exposed to enriched en-
vironment conditions for 5 months. During the last month,
we documented the behavior and activity of a subset
of these animals in the “enrichment” cage. Seven male
mice at the age of 1 month were maintained in standard
housing conditions for 5 months, and these served as
the control group. Animals were euthanized and brain
sections were probed with 3D6 antibodies, specific for
an epitope at or near the amino terminus of Aβ (Kim et
al., 2001). Bound antibodies were detected by fluores-
cently labeled secondary antibodies and visualized by
confocal microscopy. We observed a dramatic reduc-
tion in amyloid deposition in the cortex and hippocam-
pus of enriched mice compared to standard housing
counterparts (Figure 1A). Morphometric analysis of 3D6-immunoreactive brain sections confirmed that enriched
mice exhibited significantly less amyloid burden in the
hippocampus and cortex compared to standard hous-
ing mice (Figure 1B). Thioflavine S staining revealed a
reduced abundance and size of deposits with fibrillar
Aβ in enriched mice (Figures 1Ca and 1Cb) compared
to standard housing mice (Figures 1Cc and 1Cd). Co-
staining of brain sections with thioflavine S and 3D6
antibodies revealed overlap in staining at the core of
the amyloid deposits in sections from either enriched
or standard mice (compare Figures 1Ce and 1Cf to 1Cg
and 1Ch, respectively). However, 3D6 immunoreactivity
in the plaque periphery in enriched mice was reduced
compared to standard housing mice (compare Figures
1Ce and 1Cf to 1Cg and 1Ch, respectively).
To examine a possible correlation between the extent
of amyloid deposition and activity of the mice in the
enriched environment, we documented the behavior of
six enriched mice during the last month prior to sacri-
fice. Some mice were highly active, spending more than
40% of their enrichment time running on the running
wheels, while others had low activity (Figure 2A). Re-
markably, enriched mice exhibiting high activity levels
showed the most significant reductions in amyloid bur-
den (Figure 2B). Thus, at least in this small cohort of
animals, exercise appears to play a significant role in
modulating amyloid deposition.
Cell
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hWe considered the possibility that reduced Aβ deposi-
tion in brains of enriched mice is due to lower steady- 1
estate levels of Aβ itself. To examine this issue, we pre-
pared detergent and formic acid extracts of hemibrains A
bfrom seven standard housing animals and six enriched
mice and quantified Aβ levels in these samples. In b
4agreement with the morphometric studies, sandwich
ELISA analyses revealed that levels of detergent- (Fig- S
rures 3A and 3B) and formic acid-soluble (Figures 3C
and 3D) Aβx-40 (Figures 3A and 3C) and AβX-42 (Figure w
m3B and 3D) peptides were significantly reduced in the
brains of the enriched mice compared to standard t
dhousing mice. The marked reduction of detergent-
insoluble, formic acid-extractable AβX-40 and AβX-42 p
Speptides in brain extracts of the enriched mice agrees
with our earlier observations of reduced numbers and s
gsize of thioflavine S-positive deposits in brain sections
of enriched mice. c
pTo assess whether alterations in APP processing might
account for the reduction in Aβ levels, we subjected l
detergent-soluble extracts to Western blot analysis to
examine the steady-state levels of APP, soluble APP E
aderivatives (sAPP), membrane-tethered APP carboxyl-
terminal derivatives (APP-CTF), and Aβ peptides. We O
rnoted slight variations in levels of full-length APP in
brain extracts prepared from both standard housing m
pand enriched groups, but these were fully consistent
with the variations observed with a protein-loading h
scontrol, α-tubulin (see Figures S1Aa and S1Ad, respec-
tively, in the Supplemental Data available with this arti- m
tcle online; quantification in Figure S1Ba). Similarly, dif-
ferences in levels of APP-CTFs levels between samples a
eparallel the variation in full-length APP or α-tubulin (Fig-
ure S1Ab; quantification in Figures S1Bb and S1Bd). In w
icontrast, the levels of detergent-extractable Aβ pep-
tides in brains of most of the enriched mice samples rFigure 3. Reduced Steady-State Levels of
Cerebral Aβ in the Brains of Enriched Mice
Cerebral steady state levels of Aβx-40/42 were
quantified by sandwich ELISA (Suzuki et al.,
1994). Levels of Aβx-40 and Aβx-42 were signifi-
cantly reduced in both detergent-soluble (A
and B) and formic acid-soluble (C and D)
brain extracts of enriched mice (Enr) com-
pared to standard housing (SH) mice
(mean ± SE, ANOVA; for (A), p % 0.0287; for
(B), p% 0.02228; for (C), p% 0.0404; for (D),
p % 0.0010).ere considerably lower than those from standard
ousing mice. (Figures S1Ac and S1Ad, compare lanes
0–16 with lanes 5–9, respectively). Considerable differ-
nces were observed in levels of detergent-extractable
β peptides detected by Aβ N-terminal-specific anti-
ody 3D6 (see Figure S1Ac) or an end-specific anti-
ody, 2G3, that detects the carboxyl-terminus of Aβ1–
0, 11–40, or 17–40 (DeMattos et al., 2001; Figure
1Ad). Most notably, the last three samples in the en-
iched group (Figures S1Ac and S1Ad, lanes 16–18)
ere animals with the highest amyloid burden. Densito-
etric quantification of the immunoblots revealed that
he levels of total Aβ and Aβ11/40 were significantly re-
uced in extracts from brains of enriched mice com-
ared to standard housing mice (Figures S1Bc and
1Bf for Aβ and Figure S1Bd for Aβx-40), findings that
upport the sandwich ELISA assays. These results sug-
est that, while the enrichment protocol has little dis-
ernable impact on APP processing in the CNS, this
rocedure has a profound impact on the steady-state
evels of Aβ peptides.
levated Activity of Neprilysin,
n A-Degrading Protease
ur finding that cerebral levels of soluble Aβx-40 were
educed in brains of enriched mice suggested that there
ight be an increase in the activity of an Aβ-degrading
rotease. Taken together with our finding that insoluble,
ighly fibrillogenic Aβx-42 peptides were reduced further
uggested that an Aβ clearance and/or degradation
echanism(s) might be enhanced. We first considered
he possibility that the activity of Aβ-degrading prote-
ses might have been upregulated in the brains of mice
xposed to enriched environment. To test this proposal,
e examined the enzymatic activity of two proteases
mplicated in Aβ degradation in vitro and in vivo: nep-
ilysin (NEP), w97 kDa membrane bound zinc metal-
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705loendopeptidase (Turner et al., 2001); and insulysin (in-
sulin-degrading enzyme; IDE), an w110 kDa thiol zinc
metalloendopeptidase (Farris et al., 2003; Miller et al.,
2003). We first examined NEP activity in brains of
6-month-old nontransgenic mice compared to 6-month-
old standard housing mice (Figure 4A) and found that
there was slight reduction in NEP activity in brain ex-
tracts of the transgenic animals (Figure 4A). We consid-
ered the possibility that the reduction in neprilysin ac-
tivity in the brains of transgenic animals with amyloid
deposition might be the result of competition from high
levels of endogenous Aβ in the assay preparation. To
examine this issue, we measured NEP activity in brain
extracts from three 6-month-old nontransgenic mice
“spiked” with up to 2000 pmols/gm purified Aβ40. These
studies failed to reveal any inhibitory effect of purified
Aβ on endogenous NEP activity (data not shown). While
there is no clear explanation for the observed difference
in NEP activity between nontransgenic and standard
housed mice, the observation is consistent with the
finding that, in AD brain, neprilysin is reduced w50%
relative to controls in regions of high plaque content
but is unchanged in brain areas with moderate or lowFigure 4. Elevated Neprilysin Activity in Brains of Enriched Mice
(A) Average NEP activity in the brain of nontransgenic (NT), enriched (Enr), and standard housing (SH) mice (mean ± SE; ANOVA, p% 0.0128).
NEP activity is increased in brains of mice that were exposed to enriched conditions, compared to mice kept in standard housing conditions.
(B) NEP activity as a function of amyloid deposition. An inverse relation is observed between amyloid burden and NEP activity in brains of
enriched mice (standard housing, dashed line; enrichment, solid line).
(C) Activity level of IDE in brains of enriched and standard housing mice (mean ± SE). Differences between IDE activity levels in brains of
enriched and standard housing mice were found to be nonsignificant.plaque burden (Yasojima et al., 2001a; Yasojima et al.,
2001b). In any event, the most striking finding of this
study is that NEP activity was significantly elevated in
brain extracts from enriched mice compared to stan-
dard housed animals (Figure 4A). Moreover, NEP activ-
ity was inversely related to amyloid deposition in the
brains of enriched mice (Figure 4B). In contrast, IDE
activity in extracts from brains of enriched and stan-
dard housing mice were quite similar (Figure 4C). We
interpret our studies to suggest that reductions in Aβ
levels in enriched mice might, at least in part, be the
consequence of elevated NEP activity.
Elevated Expression of Immediate Early Genes
in Brains of Enriched Mice
Although elevated NEP activity in brains of enriched
mice might contribute to the lowering of Aβ levels and
Aβ deposition, it was equally conceivable that addi-
tional mechanisms might be operative that influence
aspects of Aβ production and/or deposition. In order to
develop an unbiased understanding of gene expression
changes that occur in brains of enriched mice, we em-
ployed a two-step microarray analysis strategy of a co-
Cell
706Table 1. Differentially Expressed Genes between Enriched and Standard Housing Mice across Two Cohorts
ALR ALR ALR ALR Pval
Probe Set Gene Accession LocusLink E1R1 E1R2 Pval E1 E2 Pval E2 comba comb
1423100_at FBJ osteosarcoma AV026617 14281 1.47 1.60 0.00003 1.68 0.00001 1.61 0.00000
oncogene
1418687_at Activity regulated NM_018790 11838 1.09 1.35 0.00010 1.44 0.00003 1.33 0.00000
cytoskeletal-
associated protein
1417065_at Early growth response 1 NM_007913 13653 1.07 1.22 0.00075 1.00 0.00211 1.07 0.00002
1448830_at Dual specificity NM_013642 19252 0.81 1.22 0.00000 0.89 0.00016 0.95 0.00000
phosphatase 1
1415899_at Jun-B oncogene NM_008416 16477 0.77 0.79 0.00023 1.02 0.00071 0.90 0.00000
1416505_at Nuclear receptor NM_010444 15370 0.70 0.86 0.00014 0.87 0.00008 0.82 0.00000
subfamily 4, group A,
member 1
1427683_at Early growth response 2 X06746 13654 0.56 0.50 0.00027 0.93 0.00054 0.73 0.00000
1422134_at FBJ osteosarcoma NM_008036 14282 0.46 0.40 0.01754 0.64 0.00186 0.54 0.00037
oncogene B
1415834_at Dual specificity NM_026268 67603 0.35 0.69 0.03369 0.50 0.00806 0.51 0.00250
phosphatase 6
1449977_at Early growth response 4 NM_020596 13656 0.40 0.55 0.00173 0.53 0.00731 0.50 0.00016
1416129_at RIKEN cDNA 1300002F13 NM_133753 74155 0.38 0.58 0.03723 0.50 0.00252 0.49 0.00097
gene
1427351_s_at Heavy chain of IgM BB226392 16019 0.43 0.25 0.04288 0.53 0.00426 0.44 0.00175
1448306_at NFkappa light chain gene NM_010907 18035 0.28 0.68 0.00171 0.37 0.00805 0.43 0.00017
enhancer, alpha
1448890_at Kruppel-like factor 2 NM_008452 16598 0.54 0.37 0.01317 0.33 0.00017 0.39 0.00003
1449731_s_at NFkappa light chain gene AI462015 18035 0.21 0.39 0.00537 0.40 0.00459 0.35 0.00029
enhancer, alpha
1416442_at Immediate early response 2 NM_010499 15936 0.31 0.23 0.00842 0.38 0.00070 0.32 0.00008
1436893_a_at axotrophin BE288026 57438 −0.49 −0.25 0.01383 −0.38 0.00095 −0.38 0.00016
Seventeen genes showed differential expression across the two cohorts of biological replicates. E1R1, experiment 1, technical replicate 1;
E1R2, experiment 1, technical replicate 2; E2, experiment 2 (biological replicate); ALR comb, average log ratio across the biological replicates;
Pval comb, p value across the biological replicates. Note that 16 of 17 probe sets showed increased expression.
a Average log ratio (ALR) = 1 corresponds to a 2-fold change.hort of APPswe X PS1E9 mice that were exposed to t
benvironmental enrichment from the time of weaning for
2 months to a cohort of mice housed under standard
cconditions. The 3 month time point was chosen to un-
cover transcriptome changes that preceded amyloid c
ideposition and to maximize the discovery of tran-
scriptome changes that may be causally related to al- o
sterations in Aβ metabolism and the development of mi-
cropathology. This strategy also allowed us to avoid A
aexpression changes that are secondary to amyloid de-
position in the brain tissue. F
hWe first performed duplicate microarray analysis on
hippocampal tissue from three enriched and four stan- s
pdard housing mice. Based on this data set, we defined
an enrichment-dependent transcriptome profile. The s
pvalidity of the determined profile, which also served as
our hypothesis, was tested in a second microarray ex- s
dperiment on a new cohort of four enriched and four
control mice at 3 months of age. Using this biological A
dreplicate data set validation strategy, 17 genes were
identified as differentially expressed (Table 1) with a a
tfalse discovery rate of <5.9% (Figure S2). Sixteen of the
genes showed increased expression in the hippocampi s
sof enriched animals, while a single gene transcript was
underexpressed. The vast majority of these transcripts p
ware encoded by immediate early genes (IEGs) that con-
trol early transcriptional activation. Two-way hierarchi- e
cal clustering in Genes@Work (Califano et al., 2000) for
the 17 genes correctly classified the samples according po enrichment phenotype in both of the technical and
iological replicate experiments (Figure 5A).
In addition to the validation strategy across the two
ohorts of animals, we performed a direct groupwise
omparison of the seven enriched and eight control an-
mals. In addition to the same 17 genes identified with
ur first comparison strategy, we found 24 more probe
ets that showed a highly significant (p < 0.01 and
LR > |0.263|) change across the enriched and control
nimals (Table 2) (Seo et al., 2004) with an estimated
DR of 5.5% (Figure S3). These results showed also a
igh concordance with a secondary Significance Analy-
is of Microarrays (SAM) examination. Of the total of 41
robe sets, 13 were redundant and encoded six of the
ame genes. Interestingly, the enriched animals re-
orted more frequent and more robust (36/41 probe
ets; mean ALR = 0.55) overexpression of genes than
ownregulation of transcripts (5/41 probe sets; mean
LR = −0.31). Two-way clustering of the expression
ata of these 41 probe sets also separated the enriched
nd control animals according to their correct pheno-
ypes (Figure 5B). Again, the vast majority of genes
howing expression change were related to early tran-
criptome activation, and these genes encoded poly-
eptides involved in a variety of processes associated
ith learning and memory, vasculogenesis, neurogen-
sis, and cell survival pathways (see Discussion).
In addition to the latter “data-driven” analysis ap-
roach, we also performed a “knowledge-based” ex-
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707ploration of our data set. Namely, the levels of tran-
scripts encoding transthyretin (TTR), prostaglandin D2
synthase (PDGS2), insulin-like growth factor 2 (IGF2),
insulin-like growth factor 2 binding protein (IGFBP2),
and ectonucleotide pyrophosphatase (ENP2) have
been shown to be elevated in the Tg2576 transgenic
mouse that overexpresses APPswe and at a time point
well before the onset of Aβ deposition (Stein and John-
son, 2002). Stein and Johnson (2002) suggested that
the expression of these latter genes, involved in Aβ se-
questration (TTR) and cell survival pathways (IGF-2,
IGFBP2), were responsible for the lack of neurodegen-
eration in the Tg2576 mouse model. When we exam-
ined the expression level of these transcripts across
the cohort of enriched animals and standard housed
controls, we found considerable individual variability
between animals in both the control and experimental
groups (data not shown). To uncover potentially signifi-
cant data that is lost in the individual variability of the
animals, we decided to focus our attention on mice that
all originated from the same parents (five in the en-
riched group, two in standard housing controls) (Figure
S4). Comparison of the microarray data for these mice
revealed a remarkable upregulation of TTR and PDGS2
in the animals that were subject to environmental en-
richment. Three independent probes reported an 11.2-
to 44.3-fold increase in TTR transcripts (one-tailed p <
0.05; Figures S4A and S4B). Furthermore, two indepen-
dent PDGS2 probes reported a 2.1- to 2.3-fold upregu-
lation in the experimental mice (p = 0.002; Figure S4C).
In addition, two probes of ENP2 reported a 1.6- to 5.1-
fold increase in the enriched mice (p = 0.017 and p =
0.084, respectively; Figure S4D). Finally, both IGF2 and
IGFBP2 reported modestly increased mean expression
levels that did not reach statistical significance (p =
0.155 and p = 0.076, respectively; Figures S4E and S4F,
respectively). Importantly, the expression levels of TTR,
PDGS2, and ENP2 were highly correlated between
these mice (TTR-PDGS2, r = 0.76; TTR-ENP2, r = 0.93;
PDGS2-ENP2, r = 0.87), suggesting that these genes
may be part of a coregulated transcript network.
Discussion
We have employed transgenic mice that overexpress
FAD-linked APP and PS1 transgenes to test the hypoth-
esis that activity would modulate APP and Aβ metabo-
lism in vivo. We chose to address this issue using an
experimental paradigm termed environmental enrich-
ment, a procedure shown to significantly improve mem-
ory function associated with profound morphological
changes in synaptic and dendritic architecture as well
as enhanced vascular plasticity and neurogenesis (for
review, see Churchill et al. [2002]). This experimental
paradigm has allowed us to offer several critical in-
sights that may have a profound significant impact on
developing strategies for the prevention of Alzheimer’s
disease.
First, we show that exposure of male transgenic mice
to an enriched environment from the time of weaning
until the age of 6 months results in a marked reduction
in Aβ deposition in the CNS compared to mice held instandard housing conditions. Remarkably, the reduc-
tion in Aβ burden in this cohort of enriched mice is in-
versely correlated with physical activity, as defined as
the time spent on the running wheel. In this regard, evi-
dence has accrued to suggest that exercising and
physical training may impede aging-related processes
(for review, see Mattson [2000] and Mattson et al.
[2001]), induce structural changes and recovery from
memory deficits and brain lesions (Rampon et al.,
2000), and ameliorate cognitive function in older adults
and AD patients (for review, see Kramer et al. [2002]).
While the inverse correlation between running and am-
yloid deposition is provocative, it will be necessary to
evaluate the phenomenon in larger cohorts of animals
and to isolate exercise from the other visual, social, and
spatial stimuli in the enriched environment before arriv-
ing at definitive conclusions about the unique role of
physical activity in modulating Aβ deposition. Second,
we demonstrate that steady-state levels of soluble and
formic acid-soluble Aβ peptides are reduced in brains
of enriched mice compared to standard housing mice.
Western blot analyses revealed that enrichment does
not profoundly alter APP processing but alters the
levels of accumulated Aβ peptides.
It is important to note that, in contrast to our findings,
Jankowsky and colleagues recently reported that envi-
ronmental enrichment enhances amyloid deposition
and steady-state Aβ levels in a different mouse strain
that coexpresses APPswe and PS1E9 (Jankowsky et
al., 2003). However, we note several critical differences
in the experimental approaches: first, subjects in the
report of Jankowsky et al. (2003) were females, in con-
trast to the males used in the present report; in this
regard, there is a clear but poorly understood enhance-
ment of amyloid burden in females compared to age-
matched males (Wang et al., 2003). Second, there was
a 2:1 ratio of mice to running wheels in our study, in
contrast to the 8:1 ratio in the report by Jankowsky et
al. (2003); the latter setting was likely to generate hier-
archical competition and stress for access to wheels,
potentially blunting the salutary effects of enrichment.
Finally, subjects culled from the enrichment colony at
various points in the Jankowsky study (Jankowsky et
al., 2003) were replaced with new individuals; such
group reorganization is a well-characterized model for
inducing sustained social stress (Blanchard et al., 2003;
Sapolsky, 1993), again potentially off-setting the effects
of enrichment.
Third, we show that the activity of an Aβ-degrading
protease, neprilysin, is elevated in brains of enriched
mice compared to nontransgenic mice or mice raised in
standard housing conditions. These data are consistent
with several in vivo studies showing that ectopic over-
expression of NEP in brains of transgenic mice leads
to reduced Aβ deposition and clearance of preexisting
Aβ deposits (Iwata et al., 2004; Marr et al., 2003).
Fourth, we employed high-density oligonucleotide
arrays to an unbiased assessment of gene expression
changes that occur in brains of enriched mice com-
pared to standard housed animals. Direct groupwise
comparison of seven enriched and eight control ani-
mals revealed a total of 41 probe sets that showed a
highly significant change across the enriched and con-
trol animals, with 13 of these probe sets being redun-
Cell
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709Nur77, and Zif268, are markedly downregulated in factors may have a profound impact on Aβ clearance
Figure 5. Hierarchical Clustering of Gene Probe Sets
(A) Two-way hierarchical clustering of 17 gene probe sets identified in Table 1. Gene probes are represented by rows with corresponding
GenBank accession numbers, and columns represent experimental animals (red, enriched; black lines, controls). RMA-standardized log2
intensity values are clustered based on Euclidian distance. Colored squares represent increased (red) or decreased expression (green) for a
single gene in a single animal. Color brightness is proportional to the magnitude of expression difference. Left and middle panels represent
two independent technical replicates originating from the same mice. Right panel corresponds to a biological replicate on a new cohort of
animals. Note that the experimental animals correctly cluster according to their genotype in all panels. Furthermore, the enriched animals
report increased expression for 16 of 17 genes.
(B) Two-way hierarchical clustering of 41 gene probe sets identified in Table 2. Figure layout similar to that described in Figure 5A. These
genes included all the 17 gene probe sets showing differential expression identified in Figure 5A and Table 1. For six genes, multiple probe
sets obtained identical results. Of the 41 probe sets, only five reported decreased expression.dant. The vast majority of genes showing elevated ex-
pression encode polypeptides involved in a variety of
processes associated with learning and memory, vas-
culogenesis, neurogenesis, and cell survival pathways.
Consistent with earlier studies that exercise induces
angiogenesis in the CNS following environmental en-
richment (Black et al., 1990; Isaacs et al., 1992; Swain
et al., 2003), we observed elevated expression of mRNA
encoding EGR-1 (or NGF-1A, Zif268), a zinc finger tran-
scription factor that is rapidly induced by a variety of
stimuli, including growth factors, cytokines, and hyp-
oxia, and plays a critical role in the expression of down-
stream genes that regulate angiogenesis (Abe and
Sato, 2001; Mechtcheriakova et al., 1999; Silverman
and Collins, 1999). In this regard, transcripts encoding
a transcriptional regulator of endothelial cell activation,
termed Kruppel-like factor (KLF2) (SenBanerjee et al.,
2004), are also elevated in the hippocampi of enriched
mice.
Transcripts encoding brain-derived neurotrophic fac-
tor (BDNF), implicated in long-term synaptic plasticity
in the adult hippocampus, are significantly upregulated
in brains of our enriched mice and have long been
known to be elevated in animals following exercise
(Farmer et al., 2004; Tong et al., 2001). Similarly, the
enrichment-dependent upregulation of serum and glu-
cocorticoid-inducible protein kinase (SGK) in the hippo-
campus of our enriched mice has been shown to be
elevated in hippocampus of environmentally enriched
rats (Lee et al., 2003) and correlates with memory con-
solidation in spatial learning paradigms (Tsai et al., 2002).
We also observed marked elevations in levels of tran-
scripts associated with neurogenesis, known to occur
in the dentate gyrus as a consequence of environmen-
tal enrichment (Kempermann et al., 1997; Kempermann
et al., 1998; van Praag et al., 1999). For example, ex-
pression of mRNA encoding B cell translocation gene
2 (Btg2) has been shown to be induced in vivo during
neurogenesis (Iacopetti et al., 1999) and is transiently
upregulated during differentiation of NGF-treated PC12
cells (el-Ghissassi et al., 2002).
What is the functional significance of the upregula-
tion of the immediate early genes (IEGs) and other
factors involved in memory retrieval and consolidation
in the enriched APPswe X PS1E9 mice? We have not
performed any physiological or behavioral analyses of
standard housing versus enriched mice, and further be-
havioral studies in this direction are clearly warranted.
However, the expression of several IEGs, including Arc,brains of mice that coexpress mutant APP and PS1
transgenes at a time when these mice exhibit cognitive
dysfunction (Dickey et al., 2003; Dickey et al., 2004). On
the other hand, we now show that the levels of these
IEGs were significantly upregulated in the hippocam-
pus of enriched mice compared to mice kept in stan-
dard housing conditions. We suggest that the microar-
ray results in enriched mice might be predictive of
improvements in cognition in these animals, but addi-
tional studies will be necessary to examine this issue.
In this regard, a recent study by Arendash and col-
leagues (Arendash et al., 2004) revealed that exposure
of older APPswe mice to an enriched environment lead
to global, overall improvement in cognitive function
across several behavioral tasks that was not associ-
ated with a change in brain Aβ deposition.
In addition to upregulated expression of transcripts
encoded by the IEGs, we also identified a set of tran-
scripts shown previously to be elevated in brains of
APPswe transgenic mice prior to the onset of Aβ depo-
sition. These transcripts, encoding transthyretin (TTR),
prostaglandin D2 synthase (PDGS2), insulin-like growth
factor 2 (IGF2), insulin-like growth factor 2 binding
protein (IGFBP2), and ectonucleotide pyrophosphatase
(ENP2), have been argued to be neuroprotective (Stein
and Johnson, 2002). The elevation in TTR levels in
APPswe mice at an early age (Stein and Johnson, 2002)
and in enriched mice may lead to sequestration of solu-
ble Aβ peptides and, ultimately, their toxicity. PDGS2 is
expressed at very high levels in the choroids plexus
and exhibits high-affinity binding to lipophilic molecules
(Urade and Hayaishi, 2000), leading us to speculate that
Aβ might also be bound by this polypeptide. Ecto-
nucleotide phosphohydrolase (CD39), expressed in
microglia, endothelial cells, and smooth muscles of the
cerebral vasculature (Braun et al., 2000), is induced by
hypoxia and appears to modulate endothelial barrier
function in this setting (Eltzschig et al., 2003; Pinsky et
al., 2002).
In summary, we provide the first experimental evidence
that exposure to environmental enrichment markedly re-
duces Aβ levels and amyloid deposition in brains of
transgenic mice and that the effects may, at least in
part, be mediated by alterations in Aβ catabolism or Aβ
sequestration. Finally, the demonstration that enrich-
ment enhances expression of genes known to regulate
vasculogenesis offers the provocative suggestion that
modifications of the blood-brain barrier and associated
Cell
710Table 2. Differentially Expressed Genes between Seven Enriched and Eight Standard Housing Mice
Probe Set Gene Name Symbol Accession LocusLink ALRb pVal SAM dval SAM Rank
1423100_at FBJ osteosarcoma oncogene Fos AV026617 14281 1.64 0.00000 −7.41 −1
1418687_at Activity regulated cytoskeletal- Arc NM_018790 11838 1.36 0.00000 −6.49 −2
associated protein
1417065_at Early growth response 1 Egr1 NM_007913 13653 1.10 0.00009 −4.17 −6
1448830_at Dual specificity phosphatase 1 Dusp1 NM_013642 19252 0.99 0.00019 −3.81 −7
1415899_at Jun-B oncogene Junb NM_008416 16477 0.92 0.00000 −4.94 −3
1416505_at Nuclear receptor subfamily 4, Nr4a1 NM_010444 15370 0.85 0.00001 −4.47 −4
group A, member 1
1416041_at Serum/glucocorticoid regulated Sgk NM_011361 20393 0.75 0.00055 −3.24 −9
kinase
1427683_at Early growth response 2 Egr2 X06746 13654 0.74 0.00001 −4.36 −5
1425281_a_at Glucocorticoid-induced leucine Gilz AF201289 14605 0.64 0.00023 −3.29 −8
zippera
1415834_at Dual specificity phosphatase 6 Dusp6 NM_026268 67603 0.54 0.00403 −2.43 −22
1422134_at FBJ osteosarcoma oncogene B Fosb NM_008036 14282 0.54 0.00014 −3.19 −10
1416755_at DnaJ (Hsp40) homolog, subfamily Dnajb1 NM_018808 81489 0.52 0.00224 −2.55 −18
B, member 1a
1416129_at RIKEN cDNA 1300002F13 genea na NM_133753 74155 0.50 0.00035 −2.92 −11
1420772_a_at Glucocorticoid-induced leucine Gilz NM_010286 14605 0.49 0.00058 −2.80 −15
zippera
1449977_at Early growth response 4 Egr4 NM_020596 13656 0.49 0.00064 −2.77 −16
1416250_at B cell translocation gene 2, Btg2 BG965405 12227 0.49 0.00041 −2.86 −13
anti-proliferative
1449262_s_at RIKEN cDNA 9130007B12 gene na BB704337 108852 0.48 0.00462 −2.32 −23
1449773_s_at Growth arrest and DNA-damage- Gadd45b AI323528 17873 0.48 0.00030 −2.90 −12
inducible 45 betaa
1417185_at Lymphocyte antigen 6 complex, Ly6a BC002070 110454 0.46 0.00192 −2.48 −20
locus A
1416756_at DnaJ (Hsp40) homolog, subfamily Dnajb1 AK002290 81489 0.45 0.00492 −2.25 −26
B, member 1a
1417602_at Period homolog 2 (Drosophila) Per2 NM_011066 18627 0.43 0.00828 −2.10 −30
1427351_s_at Immunoglobulin heavy chain 6 Igh-6 BB226392 16019 0.43 0.00167 −2.45 −21
(heavy chain of IgM)
1448306_at NF kappa B light chain gene Nfkbia NM_010907 18035 0.41 0.00083 −2.53 −19
enhancer, alphaa
1448890_at Kruppel-like factor 2 Klf2 NM_008452 16598 0.38 0.00028 −2.65 −17
1422168_a_at Brain derived neurotrophic factor BDNF NM_007540 12064 0.38 0.00268 −2.24 −27
1416105_at Nicotinamide nucleotide Nnt BC008518 18115 0.35 0.00153 −2.26 −25
transhydrogenase
1449731_s_at NF kappa B light chain gene Nfkbia AI462015 18035 0.34 0.00178 −2.21 −28
enhancer, alphaa
1416442_at Immediate early response 2 Ier2 NM_010499 15936 0.33 0.00002 −2.81 −14
1422231_a_at TNF receptor superfamily, Tnfrsf25 AF329969 85030 0.32 0.00471 −2.00 −39
member 25
1419816_s_at RIKEN cDNA 1300002F13 genea na AI788755 74155 0.31 0.00337 −2.01 −35
1415996_at Thioredoxin interacting protein Txnip NM_023719 56338 0.28 0.00795 −1.81 −46
1453851_a_at Growth arrest and DNA-damage- Gadd45g AK007410 23882 0.28 0.00024 −2.28 −24
inducible 45 gamma
1448170_at Seven in absentia 2 Siah2 NM_009174 20439 0.27 0.00108 −2.07 −31
1450350_a_at Jun dimerization protein 2 Jundm2 NM_030887 81703 0.27 0.00401 −1.89 −41
1450971_at Growth arrest and DNA-damage- Gadd45b AK010420 17873 0.27 0.00079 −2.10 −29
inducible 45 betaa
1420088_at NF kappa B light chain gene Nfkbia AI462015 18035 0.26 0.00136 −2.00 −37
enhancer, alphaa
1452170_at RIKEN cDNA 2010209012 gene na BC019714 100910 −0.29 0.00152 2.08 3
1448705_at Zinc finger protein 297 Zfp297 BC026964 81630 −0.29 0.00826 1.82 6
1437746_at RIKEN cDNA 4632401D06 gene na AV333542 74342 −0.30 0.00067 2.23 2
1417839_at Claudin 5 Cldn5 NM_013805 12741 −0.31 0.00729 1.87 5
1436893_a_at Axotrophin Axot BE288026 57438 −0.38 0.00002 3.00 1
Forty-one genes showed differential expression across the whole data set. Table layout similar to that in Table 1, with the addition of the last
two columns, which represent significance analysis of microarrays d values and rank. Thirty-six of 41 changed probe sets reported expression
increases in the enriched environment-maintained animals. The outcome of the two analytical methods almost identical—all of the 36 genes
with decreased expression in the Student’s t-test ranked in the top 46 decreased genes by SAM, and the five most increased genes we found
ranked in the top six by SAM.
a More than one probe set obtained convergent results.
b ALR of 1 = 2-fold change.
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711(DeMattos et al., 2002a; DeMattos et al., 2002b; Ji et
al., 2001; Shibata et al., 2000).
Experimental Procedures
Transgenic Mice
Mice coexpressing FAD mutant human PS1E9 and a chimeric
mouse-human APP695 harboring a human Aβ domain and muta-
tions (K595N, M596L) linked to Swedish FAD pedigrees (APPswe)
have been described previously (Lazarov et al., 2002). Background
strains include APPswe [C3H/HeJ × C57BL/6J F3] × C57BL/6J n1;
PS1E9 C3H/HeJ × C57BL/6J F3. Mice were screened for the
blindness-causing retinal degeneration rd mutation and found to
be wild-type (data not shown).
Enrichment Setting
Animal experiments were conducted in accordance with institu-
tional and NIH guidelines. Male offspring of transgenic breeding
pairs APPswe × PS1E9 were separated from their mother at 3
weeks of age (after weaning), genotyped, and housed four males
to a cage. Enriched environment was composed of large cages
(3.236 × 104 cm3), running wheels, colored tunnels, toys, and chew-
able material. For 1 month, mice were exposed to enriched environ-
ment every day for 3 hr and were returned to their original cages
for the remaining 21 hr. After 1 month of daily enrichment, mice
were introduced to the enriched environment three times a week
for an additional 4 months. Mice were sacrificed at age of 6
months. Following weaning, a control group of animals was main-
tained for 5 months in standard housing conditions.
Tissue Processing and Immunohistochemistry
Brains were isolated, and the hemispheres were separated and fro-
zen on dry ice. The right hemisphere was kept intact for immuno-
histochemistry. The left hemisphere was cut longitudinally into
three segments; the medial segment was used for examination of
protein expression by Western blot analysis (see below), the central
segment for analyzing NEP and IDE activity (see below), and the
lateral segment for Aβ quantification by ELISA (see below). The
right hemisphere was cryosectioned horizontally into 20 m sec-
tions, and sections were mounted on gelatin-coated slides. Sec-
tions were kept in −20°C until use. Immunostaining of sections,
confocal imaging, and quantification of amyloid deposition were
performed as previously described (Lazarov et al. [2002] or see
Supplemental Experimental Procedures). Thioflavine S staining
was performed as previously described (Benzing et al., 1993).
Extraction of Brain Proteins for Western Blot Analysis
Brains were homogenized in extraction buffer (50 mM Tris [pH 7.2],
150 mM NaCl, 5 mM EDTA, protease inhibitor mixture [Sigma], and
100 mM PMSF) using ground glass microhomogenizers. Following
addition of 1% SDS, the homogenate was centrifuged for 10 min
at 10,000 × g. Protein concentration of the supernatant fraction
was determined using BCA-protein assay (Pierce), and equal
amounts of proteins were analyzed by Western blot. Brain extracts
were subject to Tris-Glycine or Tris-Tricine SDS-PAGE. Proteins
were detected by Western blot analysis.
Antibodies
For Western blotting or immunohistochemistry, the following anti-
bodies were used as previously described: CT15 (Sisodia et al.,
1993), mAb22C11 (Hilbich et al., 1993; Weidemann et al., 1989),
mouse anti-α-tubulin (Sigma 1:1,000,000), anti-Aβ mAb3D6 (1:2,500,
[Kim et al., 2001]), anti-Aβ40 mAb2G3 (1:2,500), Cy5- or Cy3-conju-
gated donkey anti-mouse IgG (1:250).
Sandwich ELISA Analysis
Cerebral Aβ was detected using ELISA protocols described pre-
viously (Suzuki et al., 1994; Turner et al., 1996). To detect detergent-
soluble cerebral Aβ, brains were homogenized in RIPA buffer con-
taining protease inhibitors. Extracts were sonicated and spun at
100,000 × g for 20 min at 4°C. Insoluble pellets were further ex-
tracted in 70% formic acid by sonication and spun at 100,000 × g
for 20 min. Samples were neutralized in 1 M Tris buffer and dilutedin blocking buffer before loading on ELISA. Aβ was captured with
either JRF/cAβ40/10 or JRF/cAβ42/26, monoclonal antibodies specific
for Aβ40 and Aβ42, respectively, supplied by Dr. M. Mercken (Jans-
sen Research Foundation, Beerse, Belgium). Captured peptides
were reported with horseradish peroxidase-conjugated m266, a
monoclonal antibody recognizing residues 13–28 of Aβ (Seubert et
al., 1992).
NEP and IDE Activity Assay
Each brain was homogenized for 5 s in 1 ml of 50 mM potassium
phosphate buffer pH 7.3 containing 200 M PMSF and 5 /ml
aprotinin. The samples were centrifuged at 1000 × g for 20 min at
4°C and the supernatant fraction centrifuged again at 100,000 × g
for 10 min. The 100,000 × g supernatant fraction was used for IDE
activity measurements, while the pellet was resuspended in 200 l
of 20-mM MES (pH 6.5) containing 200 M PMSF and 5 g/ml
aprotinin and used for neprilysin activity measurements.
IDE activity was measured by following the release of trichloro-
acetic acid soluble peptides from iodinated insulin (Song et al.,
2003). Neprilysin activity was measured by following the cleavage
of glutyl-Ala-Ala-Phe-2-methoxy-4-napthylamide (Sigma) using a
coupled fluorescent assay (Li and Hersh, 1995).
Microarray Experiments
See Supplemental Experimental Procedures for a detailed descrip-
tion of microarray procedure and analyses.
Supplemental Data
Supplemental Data include four figures and Supplemental Experi-
mental Procedures and can be found with this article online at
http://www.cell.com/cgi/content/full/120/5/701/DC1/.
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